SMS Lifesciences India Ltd

SMS Lifesciences India has announced its financial results for the quarter ending December 2024, showcasing significant year-on-year growth in Profit Before Tax and Profit After Tax. However, the company faces challenges with a declining Debtors Turnover Ratio and reduced cash and cash equivalents, indicating potential liquidity issues.

SMS Lifesciences India, a microcap pharmaceutical company, has reported a strong financial performance in the second quarter of FY24-25. The company's PBT and PAT have shown significant growth year on year, while sales have also increased. However, there are concerns regarding the Debtors Turnover Ratio, Non-Operating Income, and cash and cash equivalents. Investors are advised to hold their stock and monitor the company's progress.

SMS Lifesciences India, a microcap pharmaceutical company, has reached a 52-week high and an all-time high of Rs.1664.65 on September 9th, 2024. With a 'Hold' rating from MarketsMOJO and consistently trading above its moving averages, the company has shown impressive growth and outperformed the Sensex by 232.03%.

SMS Lifesciences India, a microcap pharmaceutical company, has reached a 52-week high on September 6th, 2024, with a current price of Rs. 1664.65. The stock has been performing well, with a consecutive gain of 18.99% in the past 4 days and trading higher than its moving averages. Investors may want to monitor this company's progress in the market.

SMS Lifesciences India, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching a 52-week high on September 5, 2024. The stock has outperformed the sector and is currently trading higher than its moving averages. With a 213.10% increase in the past year, the company shows strong potential in the pharmaceutical industry.

SMS Lifesciences India, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs. 1519 on September 4th, 2024. The stock has outperformed the sector by 3.54% and has been on a consecutive gain streak for the past 2 days. It is currently trading above its moving averages and has shown a 191.77% increase in the past year, making it a promising investment option in the pharma industry.

SMS Lifesciences India, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on August 28, 2024. The stock has gained 15.78% in just three days and is currently trading higher than its moving averages. With a 192.42% increase in the past year, the company shows strong potential in the pharma sector.

SMS Lifesciences India, a microcap pharmaceutical company, has hit a 52-week high on August 27, 2024. With a 'Hold' call from MarketsMOJO, the stock has outperformed the sector by 4.62% and has been gaining for the last two days. It is currently trading higher than its moving averages and has shown a remarkable performance of 184.29% in the past year.

SMS Lifesciences India, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on August 26, 2024. The stock has outperformed the sector and is trading higher than its moving averages. With a significant increase in the past year, the company's stock has caught the attention of investors.

SMS Lifesciences India ., a microcap pharmaceutical company, has reached a 52-week high on August 19, 2024, with a stock price of Rs.1366.9. The company has shown consistent gains in the market, outperforming the sector and its moving averages. In the past year, the stock has seen a remarkable 161.35% increase, showcasing its strong performance and potential in the pharmaceutical industry.

SMS Lifesciences India ., a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching a 52-week high on August 12, 2024. The stock has outperformed the sector by 20.21% and gained 55.21% in the last 4 days. Analysts have given a 'Hold' call, and the company's stock is trading higher than its moving averages, indicating a positive outlook for investors.

SMS Lifesciences India, a microcap pharmaceutical company, has reported a strong financial performance in the quarter ending June 2024. The company's operating profit to interest ratio is the highest at 6.79 times, with consistent growth in PBT, PAT, and net sales. However, the company needs to address its slow pace of settling debtors and improve short term liquidity for sustained growth.

SMS Lifesciences India ., a microcap pharmaceutical company, has hit a 52-week high on August 9th, 2024 with a current price of Rs. 993.95. The stock has been performing well, outperforming the sector by 0.82% and showing a consecutive gain for the past 3 days. It is currently trading above its moving averages and has seen a strong performance in the past year. The company is focused on developing and manufacturing high-quality APIs and intermediates for the global market. Investors are advised to hold onto their stocks and monitor the company's progress.

SMS Lifesciences India, a microcap pharmaceutical company, has reached a 52-week high of Rs.970 on August 2, 2024, due to its strong performance and positive outlook in the pharma industry. According to MarketsMOJO, the stock call is 'Hold' based on current performance and market trends. The stock has outperformed the sector and its moving averages, with a remarkable growth of 88.12% in the past year. This highlights the company's potential in the competitive pharmaceutical market.

SMS Lifesciences India Ltd., a microcap pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on August 1st, 2024. The stock has been on an upward trend for 5 days, gaining 13.35%. It has also outperformed the sector and consistently traded above its moving averages, showcasing its strong performance and potential for growth.

SMS Lifesciences India . has seen a significant increase in its stock price, reaching a 52-week high on July 31, 2024. The company has outperformed the sector and the Sensex, with a consecutive gain in the past four days and trading higher than its moving averages. With a 'Hold' recommendation from MarketsMOJO, SMS Lifesciences India . is a promising player in the pharmaceutical industry.

SMS Lifesciences India ., a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching a 52-week high on May 29, 2024. The company's stock has been on an upward trend for the past three days, gaining 35.59%. It is currently trading higher than its moving averages and has outperformed the market in the past year, showcasing its strong growth potential.

SMS Lifesciences India . has been making headlines in the stock market as its share price reached a 52-week high of Rs.821.15 on May 28, 2024. The stock has outperformed the sector by 19.66% and gained 24.79% in the last two days. With a 'Hold' recommendation from MarketsMOJO, the stock is currently trading higher than its moving averages and has shown a 1-year performance of 46.63%, surpassing the Sensex's 20.71%.

SMS Lifesciences India, a microcap pharmaceutical company, has reported a strong financial performance in the quarter ended March 2024. The company's Profit Before Tax and Profit After Tax have shown significant growth, along with an increase in Net Sales. However, the high non-operating income and rising interest cost should be monitored closely. MarketsMOJO has given a 'Hold' call for the company's stock.